Including at least $757 million from last week, biotechs have now raised $947 million in follow-ons since Jan. 1, making this the fastest start to any year since BioCentury began tracking financings in 1994.

Biotechs also raised $465 million in three convertible note deals to bring the weekly industry total to over $1.2 billion.